Marc Mazzuca
About Marc Mazzuca
Marc Mazzuca is an Associate Director of Regulatory Affairs at Deciphera Pharmaceuticals, with a background in pharmacology and physiology. He has held various roles in regulatory affairs and medical writing across multiple pharmaceutical companies, including Takeda and Shire.
Current Role at Deciphera Pharmaceuticals
Marc Mazzuca serves as the Associate Director of Regulatory Affairs at Deciphera Pharmaceuticals. He has held this position since 2022. In this role, he is responsible for overseeing regulatory strategies and submissions, ensuring compliance with industry standards and regulations.
Career Progression at Deciphera Pharmaceuticals
Marc Mazzuca has a significant history with Deciphera Pharmaceuticals, where he progressed through various roles in Regulatory Affairs. He started as a Senior Regulatory Affairs Associate from 2018 to 2020, then advanced to Manager of Regulatory Affairs from 2020 to 2021. Following this, he served as Sr. Manager, Regulatory Affairs for six months in 2021 before assuming his current role.
Previous Experience in Regulatory Affairs and Medical Writing
Before joining Deciphera Pharmaceuticals, Marc Mazzuca worked at Shire as a Senior Medical Writer in Clinical/Regulatory for three months in 2018 and as Medical Writer II from 2016 to 2018. He also spent a brief period as a Modeling and Simulation Scientist at Takeda in 2015. His experience encompasses both regulatory affairs and medical writing.
Educational Background and Qualifications
Marc Mazzuca holds a Doctor of Philosophy (PhD) in Physiology from the University of Melbourne, which he completed from 2006 to 2010. He also obtained a Postdoctorate in Pharmacology from Harvard Medical School, studying from 2011 to 2015. Additionally, he earned a Bachelor of Science (BSc) Honours in Biology from the University of Waterloo from 2001 to 2005.
Postdoctoral Research Experience
Marc Mazzuca has extensive postdoctoral research experience, having worked at Brigham and Women's Hospital from 2011 to 2015. This role contributed to his expertise in pharmacology and regulatory affairs, enhancing his qualifications for his subsequent positions in the pharmaceutical industry.